CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, CEO sold 17,679 shares at an average $61.61 ($1,089,199)
- 4 Planned sale CHIEF LEGAL OFFICER sold 10,000 shares at $54.00 ($540,000)
- 4 Open-market sale Director sold 11,000 shares at an average $48.23 ($530,531)
- 4 Open-market sale Chief Medical Officer sold 3,650 shares at $44.71 ($163,192)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,515 shares at $44.71 ($112,446)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 2,210 shares at $44.71 ($98,809)
- 4 Open-market sale President, CEO sold 14,281 shares at $44.71 ($638,504)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 9,639 shares at an average $45.56 ($439,200)
- 4 Open-market sale Chief Medical Officer sold 2,235 shares at $45.11 ($100,821)
- 4 Open-market sale President, CEO sold 9,202 shares at $45.11 ($415,102)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,908 shares at $45.11 ($86,070)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President, CEO sold 15,309 shares at $43.26 ($662,267)
Page 2 of 15 · 297 filings